PATH Biobank

Last updated
PATHLogo.jpg

PATH Biobank (Patients' Tumor Bank of Hope) is a German biobank for breast cancer, established in 2002 from patients for patients. PATH is an independent non-profit foundation with the purpose of supporting breast cancer research with high quality tumor tissue. In order to achieve this goal, PATH operates sample storage tanks with liquid nitrogen at seven German breast centers. Tumor tissue and blood serum from breast cancer patients are stored in these tanks. More than 7200 women have consented to the storage of their tissue since 2004 (as of January 2014). A centralized database complements the biobank with important patient information. PATH is a joint venture of clinicians, scientists and patients. Via sample collection for cancer research, these partners aim to close the gap between basic science and fast implementation in the clinical practice.

Contents

Concept

Making sample collection more efficient

Establishing the infrastructure for sampling high quality tissue for basic and clinical research is time consuming and hence often impossible. [1] The property situation of the tumor tissue is often not clearly regulated, which further complicates the establishment of a tissue collection. This situation was pointed out by Prof. Dr. Axel Ullrich one of the inventors of Trastuzumab and members of the scientific advisory board of PATH. [2] Gathering follow-up data from patients is often impossible for a scientist. PATH solves these problems via centralized storage of the samples, transparent allocation criteria and routine follow-up surveys.[ citation needed ]

Strategy

In one of the cooperating clinical centers, the breast cancer patient is informed about the option to store her tissue a blood serum at PATH. In the case of her informed consent, the tumor will be split into equal parts (aliquots) immediately after the surgery and routine diagnostic. One part is stored exclusively for the patient, the other samples are donated to PATH Biobank for research purposes. The samples are processed according to strict quality standards (cGCP) in all cooperating clinics and stored in the gas phase of liquid nitrogen (about -160 °C).[ citation needed ]

Standardized and uniform sample processing

The processing, labelling and storage of the tumor and normal tissue and the blood serum aliquots is performed according to standard operation procedures (SOPs), which have been developed specially for PATH. The size of the tissue samples and maximal ischemia times, as well as clotting times for the blood samples, are regulated by the SOPs and documented.[ citation needed ]

Structure

The honorary board of the PATH Biobank consists of three individuals, according to the statute two of which need to have had breast cancer. In addition to the representation, e.g. at conferences and towards scientific partners, the board guides the activities and direction. The day-to-day business is organized by the PATH-office in Munich. The staff encompasses two permanent employees, which are supported by working students.[ citation needed ]

Documentation of patient data

The PATH database encompasses a large amount of important information, which is crucial for using the samples for research. The database solution is located on a stand-alone-computer without internet access, in order to protect the data from unauthorized access. In addition to this, personal data are stored physically separated from further data. Under no circumstances are these personal data given to third parties. The database includes information about e.g. the number of samples, ischemia/clotting times of the samples before freezing, age and gender of the patient, potential pre-existing medical conditions, type and date of diagnosis, menopausal state, staging/grading, histopathology, receptor state (HER2/neu, ER- and PR-state), recommended therapies and already performed (neoadjuvant) therapies, survival state, events (locoregional relapse, distant metastases, therapy course).[ citation needed ]

Cooperating clinics

(as of January 2014)

Bonn: Evangelische Kliniken Bonn gGmbH, Johanniter-Krankenhaus; Universitäts-Frauenklinik Bonn

Dortmund: St. Johannes-Hospital Dortmund, Brustzentrum

Bochum/Herne: Universitäts-Frauenklinik Marienhospital Herne, Kooperatives Brustzentrum Bochum/Herne; St. Annahospital, Kooperatives Brustzentrum Bochum/Herne

Kassel: Klinikum Kassel GmbH, IBZ- Interdisziplinäres Brustzentrum

Marburg: Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Brustzentrum Regio

Offenbach: Klinik für Gynäkologie und Geburtshilfe, Klinikum Offenbach GmbH

Regensburg: Klinik für Frauenheilkunde und Geburtshilfe der Universität Regensburg am Caritas-Krankenhaus St. Josef

Sample allocation

Scientists from academic groups and from industry can apply for sample allocation.

National and international biobank initiatives

In order to make biobanks more visible in Germany, the German biobank register was established, which is operated by the TMF – Technologie- und Methodenplattform für die vernetzte medizinische Forschung [3] and supported by the German Ministry for Education and Research, the Bundesministerium für Bildung und Forschung. PATH Biobank is registered in the biobank register. [4] The importance of biobanks such as PATH Biobank is also stressed by the initiative "Nationale Biobanken Initiative", which is supported with 18 Mio. Euro by the German Ministry for Education and Research. [5]

Related Research Articles

<span class="mw-page-title-main">Biopsy</span> Medical test involving extraction of sample cells or tissues for examination

A biopsy is a medical test commonly performed by a surgeon, an interventional radiologist, or an interventional cardiologist. The process involves the extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is then fixed, dehydrated, embedded, sectioned, stained and mounted before it is generally examined under a microscope by a pathologist; it may also be analyzed chemically. When an entire lump or suspicious area is removed, the procedure is called an excisional biopsy. An incisional biopsy or core biopsy samples a portion of the abnormal tissue without attempting to remove the entire lesion or tumor. When a sample of tissue or fluid is removed with a needle in such a way that cells are removed without preserving the histological architecture of the tissue cells, the procedure is called a needle aspiration biopsy. Biopsies are most commonly performed for insight into possible cancerous or inflammatory conditions.

<span class="mw-page-title-main">Immunohistochemistry</span> Common application of immunostaining

Immunohistochemistry (IHC) is a form of immunostaining. It involves the process of selectively identifying antigens (proteins) in cells and tissue, by exploiting the principle of antibodies binding specifically to antigens in biological tissues. Albert Hewett Coons, Ernest Berliner, Norman Jones and Hugh J Creech was the first to develop immunofluorescence in 1941. This led to the later development of immunohistochemistry.

Cancer staging is the process of determining the extent to which a cancer has grown and spread. A number from I to IV is assigned, with I being an isolated cancer and IV being a cancer that has metastasized and spread from its origin. The stage generally takes into account the size of a tumor, whether it has invaded adjacent organs, how many regional (nearby) lymph nodes it has spread to, and whether it has appeared in more distant locations (metastasized).

<span class="mw-page-title-main">Hybridoma technology</span> Method for producing lots of identical antibodies

Hybridoma technology is a method for producing large numbers of identical antibodies, also called monoclonal antibodies. This process starts by injecting a mouse with an antigen that provokes an immune response. A type of white blood cell, the B cell, produces antibodies that bind to the injected antigen. These antibody producing B-cells are then harvested from the mouse and, in turn, fused with immortal myeloma cancer cells, to produce a hybrid cell line called a hybridoma, which has both the antibody-producing ability of the B-cell and the longevity and reproductivity of the myeloma.

<span class="mw-page-title-main">Biobank</span> Repository of biological samples used for research

A biobank is a type of biorepository that stores biological samples for use in research. Biobanks have become an important resource in medical research, supporting many types of contemporary research like genomics and personalized medicine.

<span class="mw-page-title-main">Ernst Wertheim</span> Austrian gynecologist (1864–1920)

Ernst Wertheim was an Austrian gynecologist born in Graz.

<span class="mw-page-title-main">University Hospital Heidelberg</span> Hospital in Heidelberg, Germany

University Hospital Heidelberg is a university hospital in Heidelberg, Germany and is with 1,991 beds one of the largest medical centers in the country. It is closely linked to Heidelberg University Medical School which was founded in 1388 and is thus the oldest within the Federal Republic of Germany.

<span class="mw-page-title-main">Max Delbrück Center for Molecular Medicine in the Helmholtz Association</span>

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin is one of the 18 institutions that make up the Helmholtz Association. It combines basic molecular biology research with clinical research and is dedicated to the research foci of systems medicine and cardiovascular diseases. The research center is named after the Berlin-born biophysicist and Nobel laureate Max Delbrück. The center is headed by Maike Sander.

<span class="mw-page-title-main">Automated tissue image analysis</span>

Automated tissue image analysis or histopathology image analysis (HIMA) is a process by which computer-controlled automatic test equipment is used to evaluate tissue samples, using computations to derive quantitative measurements from an image to avoid subjective errors.

A biorepository is a facility that collects, catalogs, and stores samples of biological material for laboratory research. Biorepositories collect and manage specimens from animals, plants, and other living organisms. Biorepositories store many different types of specimens, including samples of blood, urine, tissue, cells, DNA, RNA, and proteins. If the samples are from people, they may be stored with medical information along with written consent to use the samples in laboratory studies.

A tumor bank is sometimes also referred to as a Tissue Bank, since normal tissues for research are also often collected. However, this function is distinct from a Tissue Bank which collects and harvests human cadaver tissue for medical research and education, and banks which store Biomedical tissue for organ transplantation.

Lymph node metastasis is the spread (metastasis) of cancer cells into a lymph node.

<span class="mw-page-title-main">Wilhelm Busch (surgeon)</span> German surgeon (1826–1881)

Karl David Wilhelm Busch was a German surgeon.

The University hospitals of the Ruhr University of Bochum, German Universitätsklinikum der Ruhr-Universität Bochum, abbreviated UK RUB is a syndicate of six university hospitals and associated facilities of the Ruhr University of Bochum. Founded in 2008 by the merger of formally independent hospitals the UK RUB is now a major provider of health in the Ruhr Metropolitan Region treating over 400,000 patients per year with a strong commitment to research and teaching.

<span class="mw-page-title-main">Estradiol undecylate</span> Chemical compound

Estradiol undecylate, also known as estradiol undecanoate and formerly sold under the brand names Delestrec and Progynon Depot 100 among others, is an estrogen medication which has been used in the treatment of prostate cancer in men. It has also been used as a part of hormone therapy for transgender women. Although estradiol undecylate has been used in the past, it was discontinued .The medication has been given by injection into muscle usually once a month.

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. It is a form of xenotransplantation. PDX models are used to create an environment that allows for the continued growth of cancer after its removal from a patient. In this way, tumor growth can be monitored in the laboratory, including in response to potential therapeutic options. Cohorts of PDX models can be used to determine the therapeutic efficiency of a therapy against particular types of cancer, or a PDX model from a specific patient can be tested against a range of therapies in a 'personalized oncology' approach.

<span class="mw-page-title-main">Kurt Semm</span> German gynecologist (1927–2003)

Kurt Karl Stephan Semm was a German gynecologist and pioneer in minimally invasive surgery. He has been called "the father of modern laparoscopy".

Thymidine kinase is an enzyme, a phosphotransferase : 2'-deoxythymidine kinase, ATP-thymidine 5'-phosphotransferase, EC 2.7.1.21 that catalyzes the reaction:

Ivo Meinhold-Heerlein is a German gynaecologist and obstetrician, honorary professor, university professor and deputy director of the Department of Gynaecology and Obstetrics at the University Hospital RWTH Aachen University. He is known for his work in the fields of molecular characterization of ovarian cancer.

Herbert Kuhl is a German gynecologist who has published extensively in the areas of estrogens, progestogens, menopause, hormonal contraception, and menopausal hormone therapy. His works include numerous original and review articles and several books. Kuhl is a member of many medical societies and has received various scientific awards.

References

  1. Goldmann-Posch U.: Der Knoten über meinem Herzen, Munich 1999, pp. 295
  2. advisory board of PATH biobank Website of PATH Biobank.
  3. Technologie- und Methodenplattform für die vernetzte medizinische Forschung e.V. Website of the TMF.
  4. Biobanken-Register Website of the Deutsches Biobaken-Register.
  5. Nationale Biomaterialbanken Initiative Archived 2014-02-22 at the Wayback Machine Website of the BMBF.